Skip to main content
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ADC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Contact
Imprint
Privacy Policy
Disclaimer
Supplier & partners
Contact
English
Deutsch
Company
Overview
Management
Supervisory Board
Research & Development
Portfolio overview
ADC technology
ADC Projects
Out-licensed product candidates
Funded projects
Publications
Scientific posters
Partnering
Press & Investors
Strategy and Facts
Strategy
Facts
Shareholder information
Share, Shareholder Structure, Basic Information
Financing History
Analysts
Capital Increase
Announcements
Press Releases and Ad-hoc Announcements
Financial Reports
Voting Rights
Directors' Dealings
Calendar and Presentations
Conferences & Presentations
Financial Calendar
Annual General Meeting
Corporate Governance
Corporate Bodies and Shareholdings
Statement on Corporate Governance
Declaration of Conformity
Articles of Association
Rules of Procedure of the Supervisory Board
Remuneration system of the Management Board and Supervisory Board
Remuneration Reports
Compliance
Code of Conduct
Whistleblower system
Newsletter subscription
Career
Overview
Job offers
Application process
Show all
2024
2023
2022
2021
2020
Presse- & Adhoc-Mitteilungen
29 November 2023
PM: Heidelberg Pharma gibt Veränderungen im Vorstand bekannt
PDF
29 November 2023
AH: Heidelberg Pharma gibt Veränderungen im Vorstand bekannt
PDF
15 November 2023
PM: Heidelberg Pharma erhält Patent für die Verwendung der ADC-Technologieplattform
PDF
02 November 2023
PM: Heidelberg Pharma präsentiert neue klinische Daten ihres Kandidaten HDP-101 auf der ASH-Jahrestagung 2023
PDF
12 October 2023
PM: Heidelberg Pharma AG: Zwischenmitteilung für die ersten neun Monate 2023
PDF
19 September 2023
PM: Heidelberg Pharma gibt Update zur klinischen Phase I/IIa-Studie mit dem Kandidaten HDP-101 bekannt
PDF
08 August 2023
PM: Heidelberg Pharma Partner Takeda hat Entwicklungsmeilenstein erreicht
PDF
13 July 2023
PM: Heidelberg Pharma berichtet über das erste Halbjahr 2023 und den Geschäftsverlauf
PDF
29 June 2023
AH: Heidelberg Pharma veräußert Minderheitsbeteiligung an Emergence Therapeutics
PDF
25 May 2023
PM: Heidelberg Pharma berichtet über die Ergebnisse der Hauptversammlung 2023
PDF
1
2
3
4
5
6
…
10
